Description of Collaborative Activity: |
CPTAC renewed its coordination with the FDA via a memorandum of understanding. This partnership provides regulatory science continuance on proteomic/proteogenomic analytical technologies, such 510(k) presubmissions. Partners include the Center for Devices and Radiological Health and Oncology Center of Excellence. |